{"id":"https://openalex.org/W1978103469","doi":"https://doi.org/10.1038/sj.bjc.6605767","title":"The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study","display_name":"The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study","publication_year":2010,"publication_date":"2010-07-01","ids":{"openalex":"https://openalex.org/W1978103469","doi":"https://doi.org/10.1038/sj.bjc.6605767","mag":"1978103469","pmid":"https://pubmed.ncbi.nlm.nih.gov/20628389","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2920021"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjc.6605767","doi":"https://doi.org/10.1038/sj.bjc.6605767","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6605767","pdf_url":"https://www.nature.com/articles/6605767.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/6605767.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013897432","display_name":"L. Rhoda Molife","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L R Molife","raw_affiliation_strings":["The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056423529","display_name":"Peter C.C. Fong","orcid":"https://orcid.org/0000-0003-2689-8958","observed_orcids":["https://orcid.org/0000-0003-2689-8958"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P C Fong","raw_affiliation_strings":["The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065158517","display_name":"Luisa Paccagnella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L Paccagnella","raw_affiliation_strings":["Pfizer Oncology, New London, CT, USA","Pf Izer Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Oncology, New London, CT, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Pf Izer Oncology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013567386","display_name":"Alison H. M. Reid","orcid":"https://orcid.org/0000-0001-8567-4941","observed_orcids":["https://orcid.org/0000-0001-8567-4941"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A H M Reid","raw_affiliation_strings":["The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103032196","display_name":"Heather May Shaw","orcid":"https://orcid.org/0000-0002-6545-2927","observed_orcids":["https://orcid.org/0000-0002-6545-2927","https://orcid.org/0009-0005-1092-0278"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"H M Shaw","raw_affiliation_strings":["The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101520157","display_name":"Laura Vidal","orcid":"https://orcid.org/0000-0001-7519-3319","observed_orcids":["https://orcid.org/0000-0001-7519-3319"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L Vidal","raw_affiliation_strings":["The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012989377","display_name":"Hendrik\u2010Tobias Arkenau","orcid":"https://orcid.org/0000-0002-2015-1549","observed_orcids":["https://orcid.org/0000-0002-2015-1549","https://orcid.org/0000-0003-0372-0540"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"H-T Arkenau","raw_affiliation_strings":["The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034625178","display_name":"Vasilios Karavasilis","orcid":"https://orcid.org/0000-0002-5806-9399","observed_orcids":["https://orcid.org/0000-0002-5806-9399"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"V Karavasilis","raw_affiliation_strings":["The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068368047","display_name":"Timothy Anthony Yap","orcid":"https://orcid.org/0000-0002-2154-3309","observed_orcids":["https://orcid.org/0000-0002-2154-3309"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"T A Yap","raw_affiliation_strings":["The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072116005","display_name":"David Olmos","orcid":"https://orcid.org/0000-0002-7003-4826","observed_orcids":["https://orcid.org/0000-0002-7003-4826"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D Olmos","raw_affiliation_strings":["The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034748028","display_name":"James F. Spicer","orcid":"https://orcid.org/0000-0003-3732-8491","observed_orcids":["https://orcid.org/0000-0003-3732-8491","https://orcid.org/0009-0005-6890-2128"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J Spicer","raw_affiliation_strings":["The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008444865","display_name":"Sophie C. Postel-Vinay","orcid":"https://orcid.org/0000-0001-5562-1857","observed_orcids":["https://orcid.org/0000-0001-5562-1857"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S Postel-Vinay","raw_affiliation_strings":["The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D Yin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D Yin","raw_affiliation_strings":["Pfizer Oncology, New London, CT, USA","Pf Izer Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Oncology, New London, CT, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Pf Izer Oncology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112146037","display_name":"Allan Lipton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Lipton","raw_affiliation_strings":["Penn State Hershey Medical Center, Hershey, PA, USA","Penn State Hershey Medical Center, Hershey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Penn State Hershey Medical Center, Hershey, PA, USA","institution_ids":["https://openalex.org/I82783531"]},{"raw_affiliation_string":"Penn State Hershey Medical Center, Hershey, USA","institution_ids":["https://openalex.org/I82783531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108446582","display_name":"Laurence M. Demers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L Demers","raw_affiliation_strings":["Penn State Hershey Medical Center, Hershey, PA, USA","Penn State Hershey Medical Center, Hershey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Penn State Hershey Medical Center, Hershey, PA, USA","institution_ids":["https://openalex.org/I82783531"]},{"raw_affiliation_string":"Penn State Hershey Medical Center, Hershey, USA","institution_ids":["https://openalex.org/I82783531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044542632","display_name":"Kim Leitzel","orcid":"https://orcid.org/0000-0003-2328-6083","observed_orcids":["https://orcid.org/0000-0003-2328-6083"]},"institutions":[{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K Leitzel","raw_affiliation_strings":["Penn State Hershey Medical Center, Hershey, PA, USA","Penn State Hershey Medical Center, Hershey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Penn State Hershey Medical Center, Hershey, PA, USA","institution_ids":["https://openalex.org/I82783531"]},{"raw_affiliation_string":"Penn State Hershey Medical Center, Hershey, USA","institution_ids":["https://openalex.org/I82783531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021891844","display_name":"Antonio Gualberto","orcid":"https://orcid.org/0000-0002-6590-839X","observed_orcids":["https://orcid.org/0000-0002-6590-839X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Gualberto","raw_affiliation_strings":["Pfizer Oncology, New London, CT, USA","Pf Izer Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Oncology, New London, CT, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Pf Izer Oncology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"J S de Bono","raw_affiliation_strings":["The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, Sutton, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5072378199"],"corresponding_institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":9.6494,"has_fulltext":true,"cited_by_count":84,"citation_normalized_percentile":{"value":0.98583195,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"103","issue":"3","first_page":"332","last_page":"339"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/figitumumab","display_name":"figitumumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/insulin-like-growth-factor-type-1-receptor","display_name":"insulin-like growth factor type 1 receptor","score":0.8230000138282776},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9049999713897705},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5709999799728394},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.9700000286102295},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8410000205039978},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8130000233650208},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7689999938011169},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7860000133514404},{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.9179999828338623},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.9322380423545837},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8318872451782227},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7268415689468384},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.712325394153595},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5951839685440063},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5796102285385132},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.497821569442749},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.42296847701072693},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4191528558731079},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4128105342388153},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40844979882240295},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3871039152145386},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3655606508255005},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.34648430347442627},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3281635046005249},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.20345470309257507},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D002481","descriptor_name":"Cellulitis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008231","descriptor_name":"Lymphopenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017526","descriptor_name":"Receptor, IGF Type 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1038/sj.bjc.6605767","doi":"https://doi.org/10.1038/sj.bjc.6605767","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6605767","pdf_url":"https://www.nature.com/articles/6605767.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2148973","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2920021","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:2920021","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2920021","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:20628389","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20628389","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1334869","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1334869/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BRITISH JOURNAL OF CANCER , 103 (3) pp. 332-339. (2010)","raw_type":"Article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/8b3791f1-d8dc-41bc-a286-16dfb9c498a5","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/8b3791f1-d8dc-41bc-a286-16dfb9c498a5","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molife, L, Fong, P, Paccagnella, L, Reid, A, Shaw, H, Vidal, L, Arkenau, T, KKaravasilis, V, Yap, T, Olmos, D, Spicer, J, Postel-Vinay, S, Yin, D, Lipton, A, Demers, L, Leitzel, K, Gualberto, A & de Bono, J 2010, 'The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study', BJC: British Journal of Cancer, vol. 103, no. 3, pp. 332 - 339.","raw_type":"info:eu-repo/semantics/publishedVersion"}],"best_oa_location":{"id":"doi:10.1038/sj.bjc.6605767","doi":"https://doi.org/10.1038/sj.bjc.6605767","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6605767","pdf_url":"https://www.nature.com/articles/6605767.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320313309","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48"},{"id":"https://openalex.org/F4320315071","display_name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1978103469.pdf","grobid_xml":"https://content.openalex.org/works/W1978103469.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1982619307","https://openalex.org/W1995594030","https://openalex.org/W2016767122","https://openalex.org/W2040104879","https://openalex.org/W2051839343","https://openalex.org/W2070854785","https://openalex.org/W2085520215","https://openalex.org/W2087681835","https://openalex.org/W2089171551","https://openalex.org/W2098409179","https://openalex.org/W2102995080","https://openalex.org/W2112474467","https://openalex.org/W2112564453","https://openalex.org/W2116483002","https://openalex.org/W2117350664","https://openalex.org/W2121520362","https://openalex.org/W2136137911","https://openalex.org/W2137125727","https://openalex.org/W2147909933","https://openalex.org/W2148998801","https://openalex.org/W2150863963","https://openalex.org/W2152606916","https://openalex.org/W2161513275","https://openalex.org/W2167156722","https://openalex.org/W2219193071","https://openalex.org/W2241286838","https://openalex.org/W2340451576","https://openalex.org/W2417503825","https://openalex.org/W2491374885","https://openalex.org/W2502670554","https://openalex.org/W2529461044","https://openalex.org/W2538590401"],"related_works":["https://openalex.org/W2031964028","https://openalex.org/W7033210180","https://openalex.org/W2166594813","https://openalex.org/W2104878828","https://openalex.org/W2244786128","https://openalex.org/W2224662956","https://openalex.org/W2026184168","https://openalex.org/W2094627782","https://openalex.org/W2224260816","https://openalex.org/W2152274262"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1],"phase":[2],"Ib":[3],"trial":[4],"assessed":[5],"safety,":[6],"tolerability,":[7],"and":[8,60,80,99,124,134,195,213],"maximum":[9],"tolerated":[10],"dose":[11,44],"(MTD)":[12],"of":[13,46,118,140,146,157,176,182,198],"figitumumab":[14,47],"(CP-751,871),":[15],"a":[16,128,186,202],"fully":[17],"human":[18],"monoclonal":[19],"antibody":[20],"targeting":[21],"the":[22,75],"insulin-like":[23],"growth":[24],"factor":[25],"type":[26],"1":[27],"receptor":[28],"(IGF-IR),":[29],"in":[30,131,148,207,215],"combination":[31,149,216],"with":[32,36,42],"docetaxel.":[33],"METHODS:":[34],"Patients":[35],"advanced":[37],"solid":[38],"tumours":[39],"were":[40,63,72,111],"treated":[41],"escalating":[43],"levels":[45],"plus":[48],"75":[49],"mg":[50,143],"m(-2)":[51],"docetaxel":[52,147,214],"every":[53],"21":[54],"days.":[55],"Safety,":[56],"efficacy,":[57],"pharmacokinetics":[58],"(PKs),":[59],"biomarker":[61,125],"responses":[62,110],"evaluated.":[64],"RESULTS:":[65],"In":[66],"46":[67],"patients,":[68,162],"no":[69],"dose-limiting":[70],"toxicities":[71,82],"attributable":[73],"to":[74,152,192],"treatment":[76],"combination.":[77],"Grade":[78],"3":[79],"4":[81],"included":[83],"neutropaenia":[84,87],"(n=28),":[85],"febrile":[86],"(n=11),":[88],"fatigue":[89],"(n=10),":[90],"leukopaenia":[91],"(n=7),":[92],"diarrhoea":[93],"(n=5),":[94],"hyperglycaemia,":[95],"lymphopaenia,":[96],"cellulitis,":[97],"DVT,":[98],"pain":[100],"(all":[101],"n=1).":[102],"The":[103],"MTD":[104],"was":[105,150],"not":[106],"reached.":[107],"Four":[108],"partial":[109],"observed;":[112],"12":[113],"patients":[114],"had":[115,165,185,201],"disease":[116],"stabilisation":[117],">":[119,166,189,203],"or":[120,167,190,204],"=6":[121],"months.":[122],"Pharmacokinetic":[123],"analyses":[126],"showed":[127],"dose-dependent":[129],"increase":[130],"plasma":[132],"exposure,":[133],"complete":[135],"sIGF-IR":[136],"downregulation":[137],"at":[138,178],"doses":[139],">or":[141],"=3":[142],"kg(-1).":[144],"Pharmacokinetics":[145],"similar":[151],"when":[153],"given":[154],"alone.":[155],"Out":[156],"18":[158],"castration-resistant":[159],"prostate":[160],"cancer":[161],"10":[163,183,199],"(56%)":[164],"=5":[168,191],"circulating":[169],"tumour":[170],"cells":[171],"(CTCs)":[172],"per":[173],"7.5":[174],"ml":[175],"blood":[177],"baseline:":[179],"6":[180],"out":[181,197],"(60%)":[184],"decline":[187,206],"from":[188],"<5":[193],"CTCs":[194,208],"9":[196],"(90%)":[200],"=30%":[205],"after":[209],"therapy.":[210],"CONCLUSIONS:":[211],"Figitumumab":[212],"are":[217],"well":[218],"tolerated.":[219],"Further":[220],"evaluation":[221],"is":[222],"warranted.":[223]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":8}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}